Back to Supplement Finder

CJC 1295 & Ipamorelin Blend (No DAC) X 10mg

Sold by FMI Health

INR 11,953.00

View at FMI Health
Store
fmihealth.com
Brand
Biolongevity Labs
Product type
Peptides
Collected
2026-11-20

From the retailer

Retailer description retrieved 2026-11-20. Claims are the retailer’s, not independently verified.

Description--CJC-1295 & Ipamorelin Blend - Growth Hormone Secretagogue Research Complex (10 mg, No DAC)

This peptide blend combines CJC-1295 (No DAC) and Ipamorelin, two complementary growth hormone secretagogues that act on distinct receptor pathways to amplify GH release.

 

Mechanistic Claims

  • CJC-1295 (No DAC, 5 mg)
    • Synthetic GHRH analog retaining 29 amino acids of native GHRH with four substitutions for stability and receptor affinity.
    • Stimulates pituitary GHRH receptors to increase pulsatile GH secretion.
    • Elevates circulating IGF-1 levels, supporting anabolic and regenerative pathways.
    • Mimics natural GH release patterns without prolonged receptor binding.
  • Ipamorelin (5 mg)
    • Synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂).
    • Selective ghrelin receptor agonist that triggers GH release from the pituitary.
    • High potency with minimal off-target hormonal effects (does not significantly affect cortisol, prolactin, or ACTH).
    • Provides a clean GH stimulation profile compared to other GHS compounds.

 

Synergistic Potential

  • Dual receptor targeting (GHRH + ghrelin) amplifies GH release.
  • Promotes IGF-1 elevation while maintaining physiological GH pulsatility.
  • Offers a balanced approach to studying growth hormone dynamics without excessive endocrine disruption.

 

Research Applications

  • Growth hormone secretion and regulation studies
  • IGF-1 mediated anabolic and regenerative pathways
  • Comparative analysis of GHRH vs. ghrelin receptor agonism
  • Endocrine signaling and pituitary function models

 

CJC 1295 Ipamorelin Research

CJC-1295 and ipamorelin have both been researched for their potential to stimulate growth hormone production.

 

Growth Hormone Release

In GHRH knockout mice, CJC-1295 administration normalized body weight and length, demonstrating its potential in treating growth deficiencies. Daily administration was more effective than less frequent 

 

  1. Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J., Frohman, L., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.. American journal of physiology. Endocrinology and metabolism, 291 6, E1290-4 . .
  2. Teichman, S., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J., & Frohman, L. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.. The Journal of clinical endocrinology and metabolism, 91 3, 799-805 . .
  3. Raun, K., Hansen, B., Johansen, N., Thøgersen, H., Madsen, K., Ankersen, M., & Andersen, P. (1998). Ipamorelin, the first selective growth hormone secretagogue.. European journal of endocrinology, 139 5, 552-61 . .
  4. Johansen, P., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T., Wilken, M., & Orskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 9 2, 106-13 . .
  5. Gobburu, J., Agersø, H., Jusko, W., & Ynddal, L. (1999). Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers. Pharmaceutical Research, 16, 1412-1416. .

Label-- Peptide Information

Property

Value

Peptide Name

CJC 1295

Peptide Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala- Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys

Molecular Formula

C165H269N47O46

Molecular Weight

CAS Number

446262-90-4

PubChem CID

Synonyms

CJC 1295, CJC-1295, 62RC32V9N7, DTXSID501027567

 

Property Value
Peptide Name Ipamorelin
Peptide Sequence Aib-His-D-2Nal-D-Phe-Lys
Molecular Formula C38H49N9O5
Molecular Weight 711.9 g/mol
CAS Number 170851-70-4
PubChem CID 9831659
Synonyms 170851-70-4, Ipamorelin [INN], NNC-26-0161, UNII-Y9M3S784Z6

Dosage-- This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.